Chevillard C, Brown N L, Mathieu M N, Laliberté F, Worcel M
I.N.S.E.R.M. U.300, Faculté de Pharmacie, Montpellier, France.
Eur J Pharmacol. 1988 Feb 16;147(1):23-8. doi: 10.1016/0014-2999(88)90629-2.
Trandolapril (3-100 micrograms/kg) and enalapril (10-300 micrograms/kg) were administered orally to conscious rats. Angiotensin-converting enzyme (CE) activity was inhibited in serum, heart ventricle, renal inner cortex, lung, aorta, adrenal cortex and adrenal medulla, but not in the striatum. Inhibition was maximal at 2 h and with trandolapril was maintained for 24 h. Blood pressure and heart rate were not affected by either compound. Trandolapril was 6-10-fold more potent than enalapril. Differences between trandolapril and enalapril in CE inhibition observed in heart ventricle, adrenal cortex and medulla could be due to the presence of more than one type of CE or CE-like activity.
将群多普利(3 - 100微克/千克)和依那普利(10 - 300微克/千克)经口给予清醒大鼠。血管紧张素转换酶(CE)活性在血清、心室肌、肾皮质内层、肺、主动脉、肾上腺皮质和肾上腺髓质中受到抑制,但在纹状体中未受抑制。抑制作用在2小时时达到最大,群多普利的抑制作用维持24小时。两种化合物均未影响血压和心率。群多普利的效力比依那普利强6至10倍。在心室肌、肾上腺皮质和髓质中观察到的群多普利和依那普利在CE抑制方面的差异可能是由于存在不止一种类型的CE或CE样活性。